Comparison of two dosing frequencies of subcutaneous interferon beta-1a in patients with a first clinical demyelinating event suggestive of multiple sclerosis (REFLEX): a phase 3 randomised controlled trial (Q48795479)
Jump to navigation
Jump to search
scientific article published on 4 December 2011
Language | Label | Description | Also known as |
---|---|---|---|
English | Comparison of two dosing frequencies of subcutaneous interferon beta-1a in patients with a first clinical demyelinating event suggestive of multiple sclerosis (REFLEX): a phase 3 randomised controlled trial |
scientific article published on 4 December 2011 |
Statements
1 reference
Comparison of two dosing frequencies of subcutaneous interferon beta-1a in patients with a first clinical demyelinating event suggestive of multiple sclerosis (REFLEX): a phase 3 randomised controlled trial (English)
1 reference
Ludwig Kappos
1 reference
Frederik Barkhof
1 reference
Giancarlo Comi
1 reference
Nicola De Stefano
1 reference
Mark S Freedman
1 reference
Chris H Polman
1 reference
Bernard M J Uitdehaag
1 reference
Florence Casset-Semanaz
1 reference
Brian Hennessy
1 reference
Margaretha Stam Moraga
1 reference
Sanda Rocak
1 reference
Bettina Stubinski
1 reference
4 December 2011
1 reference
1 reference
11
1 reference
1
1 reference
33-41
1 reference